aurobindo pharma (Angel) Revenue led by US and ARV formulation segments

Date Rating Target Price Recommendation Price Broker house
8 Feb 2011 buy 1415 1173 Angel Report 

+NSE Link+Reuters Link+Reuters India Link+Google Link+DSR Search

No comments:

Post a Comment